Skip Navigation

Publicaciones covid-9

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

View ORCID ProfileNicholas G. Davies1,*, View ORCID ProfileSam Abbott1,†, View ORCID ProfileRosanna C. Barnard1,†, View ORCID ProfileChristopher I. Jarvis1,†, Adam J. Kucharski1,†, View ORCID ProfileJames D. Munday1,†, View ORCID ProfileCarl A. B. Pearson1,†, View ORCID ProfileTimothy W. Russell1,†, View ORCID ProfileDamien C. Tully1,†, View ORCID ProfileAlex D. Washburne2,†, View ORCID ProfileTom Wenseleers3,†, Amy Gimma1, View ORCID ProfileWilliam Waites1, View ORCID ProfileKerry L. M. Wong1, View ORCID ProfileKevin van Zandvoort1, View ORCID ProfileJustin D. Silverman4, CMMID COVID-19 Working Group1,‡, COVID-19 Genomics UK (COG-UK) Consortium‡, Karla Diaz-Ordaz5, Ruth Keogh5, Rosalind M. Eggo1, Sebastian Funk1, Mark Jit1, Katherine E. Atkins1,6, W. John Edmunds1
?  Evaluación: (not yet rated)
Resumen

A novel SARS-CoV-2 variant, VOC 202012/01 (lineage B.1.1.7), emerged in southeast England in November 2020 and is rapidly spreading toward fixation. Using a variety of statistical and dynamic modelling approaches, we estimate that this variant has a 43–90% (range of 95% credible intervals 38–130%) higher reproduction number than preexisting variants. A fitted two-strain dynamic transmission model shows that VOC 202012/01 will lead to large resurgences of COVID-19 cases. Without stringent control measures, including limited closure of educational institutions and a greatly accelerated vaccine roll-out, COVID-19 hospitalisations and deaths across England in 2021 will exceed those in 2020. Concerningly, VOC 202012/01 has spread globally and exhibits a similar transmission increase (59–74%) in Denmark, Switzerland, and the United States.

Procedencia del autor
Texto completo
Tipo de documento
Especialidad(es)
Publicado en el sitio 2021-03-10 17:05:25

Comentarios

(aún no hay comentarios disponibles para este recurso)